A COVID-19 vaccine made in Taiwan by Medigen Vaccine Biologics Corp. has received emergency use authorization (EUA) in Paraguay after the unblinding of a Phase 3 clinical trial conducted in the South American country, the company said in a statement Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Culture
Singer-songwriter pays homage to Taiwan's democracy pioneers
06/25/2025 09:03 AM - Business
Taiwan approves Hon Hai's US$2.2 billion investment plans in India, U.S.
06/24/2025 10:08 PM - Politics
'Oppose CCP and safeguard Taiwan' key to unity: Lai
06/24/2025 10:01 PM - Society
Anker's recall of power banks affects fewer than 5,500 units in Taiwan
06/24/2025 09:38 PM - Society
Imported mayonnaise blocked at border over excessive preservatives
06/24/2025 09:25 PM